-
Je něco špatně v tomto záznamu ?
Addisonian crisis in a dog treated with phenobarbitone
V. Simerdova, I. Hajek, P. Schanilec,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
PubMed
25817975
DOI
10.1111/avj.12301
Knihovny.cz E-zdroje
- MeSH
- Addisonova nemoc chemicky indukované veterinární MeSH
- akutní nemoc MeSH
- antikonvulziva škodlivé účinky MeSH
- epilepsie generalizovaná farmakoterapie veterinární MeSH
- fenobarbital škodlivé účinky MeSH
- nemoci psů chemicky indukované MeSH
- psi MeSH
- zvířata MeSH
- Check Tag
- psi MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
BACKGROUND: A 2-year-old intact female Irish Setter was presented with a 1-week history of anorexia, lethargy, vomiting and diarrhoea. Previous medical therapy included a 3-week treatment with phenobarbitone for suspected idiopathic epilepsy. In humans, phenobarbitone accelerates metabolism of both exogenous and endogenous steroids. CASE REPORT: Based on history, the physical examination showing abnormal mentation and laboratory abnormalities including azotaemia, hyponatraemia and hyperkalaemia, Addisonian crisis was suspected. An adrenocorticotropic hormone stimulation test was performed and confirmed the diagnosis. Treatment with intravenous fluid therapy, glucocorticoids and mineralocorticoids led to a resolution of clinical signs in 3 days. CONCLUSION: To the authors' current knowledge, this is the first reported case of Addisonian crisis in a dog most probably related to phenobarbitone administration. As Addisonian crisis can be life-threatening, clinicians should be aware of this adverse effect of phenobarbitone and use it cautiously in dogs with borderline hypoadrenocorticism.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020916
- 003
- CZ-PrNML
- 005
- 20241212094127.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/avj.12301 $2 doi
- 024 7_
- $a 10.1111/avj.12301 $2 doi
- 035 __
- $a (PubMed)25817975
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Simerdova, V $u Small Animal Clinic, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho tr. 1/3, 61242, Brno, Czech Republic. simerdovav@gmail.com.
- 245 10
- $a Addisonian crisis in a dog treated with phenobarbitone / $c V. Simerdova, I. Hajek, P. Schanilec,
- 520 9_
- $a BACKGROUND: A 2-year-old intact female Irish Setter was presented with a 1-week history of anorexia, lethargy, vomiting and diarrhoea. Previous medical therapy included a 3-week treatment with phenobarbitone for suspected idiopathic epilepsy. In humans, phenobarbitone accelerates metabolism of both exogenous and endogenous steroids. CASE REPORT: Based on history, the physical examination showing abnormal mentation and laboratory abnormalities including azotaemia, hyponatraemia and hyperkalaemia, Addisonian crisis was suspected. An adrenocorticotropic hormone stimulation test was performed and confirmed the diagnosis. Treatment with intravenous fluid therapy, glucocorticoids and mineralocorticoids led to a resolution of clinical signs in 3 days. CONCLUSION: To the authors' current knowledge, this is the first reported case of Addisonian crisis in a dog most probably related to phenobarbitone administration. As Addisonian crisis can be life-threatening, clinicians should be aware of this adverse effect of phenobarbitone and use it cautiously in dogs with borderline hypoadrenocorticism.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a Addisonova nemoc $x chemicky indukované $x veterinární $7 D000224
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antikonvulziva $x škodlivé účinky $7 D000927
- 650 _2
- $a nemoci psů $x chemicky indukované $7 D004283
- 650 _2
- $a psi $7 D004285
- 650 _2
- $a epilepsie generalizovaná $x farmakoterapie $x veterinární $7 D004829
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fenobarbital $x škodlivé účinky $7 D010634
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hajek, I
- 700 1_
- $a Schánilec, Pavel $7 xx0326716
- 773 0_
- $w MED00186148 $t Australian veterinary journal $x 1751-0813 $g Roč. 93, č. 4 (2015), s. 105-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25817975 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20241212094120 $b ABA008
- 999 __
- $a ok $b bmc $g 1155586 $s 945444
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 93 $c 4 $d 105-8 $i 1751-0813 $m Australian veterinary journal $n Aust Vet J $x MED00186148
- LZP __
- $a Pubmed-20160722